Partnering
Diurnal has major competencies in the development of innovative medicines for the treatment of endocrine (hormone) disorders, and is focused on building a strong product portfolio within this field. Diurnal innovative development activities in circadian-based endocrinology have yielded novel product opportunities relating to:
- Steroid Hormone
- Testosterone
- Thyroid Hormone
Diurnal wishes to enter into development and commercialization partnerships in these and other areas to create a broad pipeline of therapeutics for endocrine diseases. Diurnal will out-license marketing rights to successful development projects once clinical proof-of-principle has been achieved.
If you wish to contact our Business Development team please click here